A novel compartmental model to capture the nonlinear trend of COVID-19

The COVID-19 pandemic took the world by surprise and surpassed the expectations of epidemiologists, governments, medical experts, and the scientific community as a whole. The majority of epidemiological models failed to capture the non-linear trend of the susceptible compartment and were unable to m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Computers in biology and medicine 2021-07, Vol.134, p.104421-104421, Article 104421
Hauptverfasser: Ramezani, Somayeh Bakhtiari, Amirlatifi, Amin, Rahimi, Shahram
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The COVID-19 pandemic took the world by surprise and surpassed the expectations of epidemiologists, governments, medical experts, and the scientific community as a whole. The majority of epidemiological models failed to capture the non-linear trend of the susceptible compartment and were unable to model this pandemic accurately. This study presents a variant of the well-known SEIRD model to account for social awareness measures, variable death rate, and the presence of asymptomatic infected individuals. The proposed SEAIRDQ model accounts for the transition of individuals between the susceptible and social awareness compartments. We tested our model against the reported cumulative infection and death data for different states in the US and observed over 98.8% accuracy. Results of this study give new insights into the prevailing reproduction number and herd immunity across the US. •A new compartmental model that captures the nonlinear behavior of the COVID-19 pandemic.•Findings on several key factors in explaining the behavior of COVID-19.•Determination of the reproduction number and the herd immunity percentage for the US.•Facilitating decision making and better explaining the behavior of the COVID-19 pandemic.
ISSN:0010-4825
1879-0534
DOI:10.1016/j.compbiomed.2021.104421